| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
|
PLoS Med
|
2008
|
4.68
|
|
2
|
Multiple-triazole-resistant aspergillosis.
|
N Engl J Med
|
2007
|
3.33
|
|
3
|
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
|
Lancet Infect Dis
|
2009
|
3.03
|
|
4
|
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
|
Antimicrob Agents Chemother
|
2006
|
2.76
|
|
5
|
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus.
|
Antimicrob Agents Chemother
|
2008
|
2.41
|
|
6
|
Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.
|
Antimicrob Agents Chemother
|
2002
|
2.26
|
|
7
|
Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification.
|
Antimicrob Agents Chemother
|
2008
|
2.17
|
|
8
|
Susceptibility patterns and molecular identification of Trichosporon species.
|
Antimicrob Agents Chemother
|
2005
|
1.92
|
|
9
|
Environmental study of azole-resistant Aspergillus fumigatus and other aspergilli in Austria, Denmark, and Spain.
|
Antimicrob Agents Chemother
|
2010
|
1.82
|
|
10
|
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.
|
Antimicrob Agents Chemother
|
2003
|
1.40
|
|
11
|
Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
|
J Antimicrob Chemother
|
2008
|
1.37
|
|
12
|
Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.
|
J Clin Microbiol
|
2011
|
1.35
|
|
13
|
G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate.
|
Antimicrob Agents Chemother
|
2003
|
1.28
|
|
14
|
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
|
Antimicrob Agents Chemother
|
2005
|
1.25
|
|
15
|
Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.
|
Antimicrob Agents Chemother
|
2009
|
1.23
|
|
16
|
Ergosterol biosynthesis pathway in Aspergillus fumigatus.
|
Steroids
|
2007
|
1.22
|
|
17
|
Susceptibility testing and molecular classification of Paecilomyces spp.
|
Antimicrob Agents Chemother
|
2008
|
1.17
|
|
18
|
Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients.
|
Intensive Care Med
|
2004
|
1.15
|
|
19
|
Members of protein O-mannosyltransferase family in Aspergillus fumigatus differentially affect growth, morphogenesis and viability.
|
Mol Microbiol
|
2010
|
1.09
|
|
20
|
In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
|
J Antimicrob Chemother
|
2004
|
1.08
|
|
21
|
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
|
Antimicrob Agents Chemother
|
2003
|
1.08
|
|
22
|
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
|
Antimicrob Agents Chemother
|
2009
|
1.07
|
|
23
|
Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.
|
J Antimicrob Chemother
|
2005
|
1.06
|
|
24
|
The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.
|
Med Mycol
|
2012
|
1.05
|
|
25
|
Aspergillus fumigatus C-5 sterol desaturases Erg3A and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility.
|
Antimicrob Agents Chemother
|
2006
|
1.05
|
|
26
|
Rapid detection of triazole antifungal resistance in Aspergillus fumigatus.
|
J Clin Microbiol
|
2008
|
1.03
|
|
27
|
Analysis of the influence of Tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp.
|
J Clin Microbiol
|
2005
|
1.02
|
|
28
|
In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
|
Antimicrob Agents Chemother
|
2008
|
1.01
|
|
29
|
Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil.
|
Med Mycol
|
2008
|
0.98
|
|
30
|
A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin.
|
J Biomol Screen
|
2012
|
0.98
|
|
31
|
Current status of antifungal resistance and its impact on clinical practice.
|
Br J Haematol
|
2014
|
0.97
|
|
32
|
Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital.
|
J Clin Microbiol
|
2004
|
0.97
|
|
33
|
Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance.
|
Front Microbiol
|
2013
|
0.97
|
|
34
|
Identification of pathogenic rare yeast species in clinical samples: comparison between phenotypical and molecular methods.
|
J Clin Microbiol
|
2010
|
0.94
|
|
35
|
Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans.
|
J Antimicrob Chemother
|
2005
|
0.94
|
|
36
|
In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.
|
Antimicrob Agents Chemother
|
2005
|
0.94
|
|
37
|
In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
|
Diagn Microbiol Infect Dis
|
2003
|
0.93
|
|
38
|
Functional analysis of the fungal/plant class chitinase family in Aspergillus fumigatus.
|
Fungal Genet Biol
|
2010
|
0.92
|
|
39
|
Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus: can MIC values be obtained at 24 hours?
|
Antimicrob Agents Chemother
|
2007
|
0.92
|
|
40
|
In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
|
Antimicrob Agents Chemother
|
2006
|
0.92
|
|
41
|
In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates.
|
Antimicrob Agents Chemother
|
2004
|
0.90
|
|
42
|
Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.
|
J Med Microbiol
|
2012
|
0.88
|
|
43
|
Clinical relevance of resistance to antifungals.
|
Int J Antimicrob Agents
|
2008
|
0.88
|
|
44
|
Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1.
|
Diagn Microbiol Infect Dis
|
2007
|
0.88
|
|
45
|
Deciphering the role of the chitin synthase families 1 and 2 in the in vivo and in vitro growth of Aspergillus fumigatus by multiple gene targeting deletion.
|
Cell Microbiol
|
2014
|
0.87
|
|
46
|
The ZrfC alkaline zinc transporter is required for Aspergillus fumigatus virulence and its growth in the presence of the Zn/Mn-chelating protein calprotectin.
|
Cell Microbiol
|
2013
|
0.87
|
|
47
|
A novel family of dehydrin-like proteins is involved in stress response in the human fungal pathogen Aspergillus fumigatus.
|
Mol Biol Cell
|
2011
|
0.86
|
|
48
|
Current section and species complex concepts in Aspergillus: recommendations for routine daily practice.
|
Ann N Y Acad Sci
|
2012
|
0.83
|
|
49
|
Three-dimensional models of 14α-sterol demethylase (Cyp51A) from Aspergillus lentulus and Aspergillus fumigatus: an insight into differences in voriconazole interaction.
|
Int J Antimicrob Agents
|
2011
|
0.82
|
|
50
|
Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
|
J Clin Microbiol
|
2012
|
0.80
|
|
51
|
Polyphasic characterization of fungal isolates from a published case of invasive aspergillosis reveals misidentification of Aspergillus felis as Aspergillus viridinutans.
|
J Med Microbiol
|
2014
|
0.79
|
|
52
|
[Are molecular techniques useful in aspergillosis surveillance and control?].
|
Enferm Infecc Microbiol Clin
|
2003
|
0.75
|
|
53
|
[Detection of Aspergillus spp. by real-time PCR in a murine model of pulmonary infection].
|
Enferm Infecc Microbiol Clin
|
2005
|
0.75
|
|
54
|
Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods.
|
J Antimicrob Chemother
|
2011
|
0.75
|